Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer.

Hill EJ, Roberts C, Franklin JM, Enescu M, West N, MacGregor TP, Chu KY, Boyle L, Blesing C, Wang LM, Mukherjee S, Anderson EM, Brown G, Dutton S, Love SB, Schnabel JA, Quirke P, Muschel R, McKenna WG, Partridge M, Sharma RA.

Clin Cancer Res. 2016 Apr 15;22(8):1922-31. doi: 10.1158/1078-0432.CCR-15-1489. Epub 2016 Feb 9.

2.

Everything Old Is New Again: Using Nelfinavir to Radiosensitize Rectal Cancer.

Meyn RE, Krishnan S, Skinner HD.

Clin Cancer Res. 2016 Apr 15;22(8):1834-6. doi: 10.1158/1078-0432.CCR-16-0024. Epub 2016 Feb 26.

3.

Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings.

Janssen MH, Ollers MC, van Stiphout RG, Buijsen J, van den Bogaard J, de Ruysscher D, Lambin P, Lammering G.

Radiother Oncol. 2010 Feb;94(2):151-5. doi: 10.1016/j.radonc.2009.12.033. Epub 2010 Jan 29.

PMID:
20116114
4.

Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer.

Cellier P, Leduc B, Martin L, Vié B, Chevelle C, Vendrely V, Salemkour A, Carrie C, Calais G, Burtin P, Campion L, Boisdron-Celle M, Morel A, Berger V, Gamelin E.

BMC Cancer. 2011 Mar 16;11:98. doi: 10.1186/1471-2407-11-98.

5.

Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.

Klenova A, Parvanova V, Georgiev R, Gesheva N.

J BUON. 2006 Apr-Jun;11(2):161-6.

PMID:
17318965
6.

Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.

Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, Delclos ME, Chang GJ, Hoff PM, Eng C, Brown TD, Crane CH, Feig BW, Morris J, Vadhan-Raj S, Hamilton SR, Lin EH.

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):762-71.

PMID:
17011451
7.

Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma.

Fakih MG, Bullarddunn K, Yang GY, Pendyala L, Toth K, Andrews C, Rustum YM, Ross ME, Levea C, Puthillath A, Park YM, Rajput A.

Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):650-7. doi: 10.1016/j.ijrobp.2008.01.020. Epub 2008 Jun 17.

PMID:
18565686
8.

Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer.

Hofheinz RD, von Gerstenberg-Helldorf B, Wenz F, Gnad U, Kraus-Tiefenbacher U, Müldner A, Hehlmann R, Post S, Hochhaus A, Willeke F.

J Clin Oncol. 2005 Mar 1;23(7):1350-7. Epub 2005 Jan 31.

PMID:
15684318
9.

Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial.

Horisberger K, Treschl A, Mai S, Barreto-Miranda M, Kienle P, Ströbel P, Erben P, Woernle C, Dinter D, Kähler G, Hochhaus A, Post S, Willeke F, Wenz F, Hofheinz RD; MARGIT (Mannheimer Arbeitsgruppe für Gastrointestinale Tumoren).

Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1487-93. doi: 10.1016/j.ijrobp.2008.10.014. Epub 2009 Jan 7.

PMID:
19131187
10.

Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer.

de Lussanet QG, Backes WH, Griffioen AW, Padhani AR, Baeten CI, van Baardwijk A, Lambin P, Beets GL, van Engelshoven JM, Beets-Tan RG.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1309-15. Epub 2005 Aug 26.

PMID:
16125874
11.

Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer.

Rödel C, Arnold D, Hipp M, Liersch T, Dellas K, Iesalnieks I, Hermann RM, Lordick F, Hinke A, Hohenberger W, Sauer R.

Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1081-6. Epub 2007 Sep 19.

PMID:
17881150
12.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
13.

Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921.

Bosset JF, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Briffaux A, Collette L.

J Clin Oncol. 2005 Aug 20;23(24):5620-7. Epub 2005 Jul 11.

PMID:
16009958
14.

A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer.

Glynne-Jones R, Sebag-Montefiore D, Maughan TS, Falk SJ, McDonald AC.

Ann Oncol. 2006 Jan;17(1):50-6. Epub 2005 Nov 10.

PMID:
16284060
15.

Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).

Vestermark LW, Jacobsen A, Qvortrup C, Hansen F, Bisgaard C, Baatrup G, Rasmussen P, Pfeiffer P.

Acta Oncol. 2008;47(3):428-33. doi: 10.1080/02841860701798866.

PMID:
18348002
17.

Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.

Myerson RJ, Michalski JM, King ML, Birnbaum E, Fleshman J, Fry R, Kodner I, Lacey D, Lockett MA.

Int J Radiat Oncol Biol Phys. 1995 Apr 30;32(1):41-50.

PMID:
7721638
18.

A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer.

Marsh Rde W, George TJ, Siddiqui T, Mendenhall WM, Zlotecki RA, Grobmyer S, Hochwald S, Chang M, Larson B, King J.

Am J Clin Oncol. 2010 Jun;33(3):251-6. doi: 10.1097/COC.0b013e3181a650e8.

PMID:
19823074
19.

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study.

Machiels JP, Duck L, Honhon B, Coster B, Coche JC, Scalliet P, Humblet Y, Aydin S, Kerger J, Remouchamps V, Canon JL, Van Maele P, Gilbeau L, Laurent S, Kirkove C, Octave-Prignot M, Baurain JF, Kartheuser A, Sempoux C.

Ann Oncol. 2005 Dec;16(12):1898-905. Epub 2005 Oct 11.

PMID:
16219623
20.

Preoperative concomitant hyperfractionated radiotherapy and gemcitabine for locally advanced rectal cancers: a phase I-II trial.

Allal AS, Bieri S, Gervaz P, Soravia C, Bernier J, Gertsch P, Morel P, Roth AD.

Cancer J. 2005 Mar-Apr;11(2):133-9.

PMID:
15969988

Supplemental Content

Support Center